The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
In this study, typical cases of blood stasis syndrome of coronary heart disease are selected,
by using microRNA chip, cDNA microarray and other bioinformatics technologies to filter and
verify related miRNA and its target gene of Coronary Heart disease. Meanwhile, intervene by
Xuesaitong soft capsules to investigate related miRNA and its target gene of Coronary Heart
disease.
Phase:
Phase 2
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences